COMMERCIALIZATION SOLUTIONS FOR THE ORTHOPEDIC INDUSTRY
MAY 2020 | VOLUME 2

Partners within the supply chain share a variety of challenges, including forecast visibility and stability, relevant capacity plans and unified response to unexpected market events. We hosted a roundtable with device companies and contract manufacturers to offer advice on overcoming these obstacles.

We look at some of the leading metals in the market and what’s pushing the development of new materials and manufacturing processes, with experts from device companies and raw material providers.

Medacta CEO Francesco Siccardi talks orthopedic opportunities, headwinds and strategies in regards to COVID-19 and market fundamentals.

FDA's orthopedic panel cleared 49 products in April; we’ve chosen updates from Arthrex, Medacta, OrthAlign, Akros Medical and Subchondral Solutions for a closer look.

In our latest Ask the Expert article, we learn how software validation fits with your SOPs for design and process validations.

The advancement of automation on the manufacturing floor requires companies to face a shift in talent acquisition and expectations, including a higher level of technical acumen.
Did You Miss these Best Practices?

Findings from a survey of 524 medical device professionals can help you benchmark yourself against best-in-class companies in the areas of product and quality management.


You've settled on a concept for your next orthopedic device. Great! These critical steps will assist you through your feasibility, development and commercialization actions.


Operations and financial managers and planners often are confused about how to calculate and use safety stock. It requires strategy, science and this specific calculation.


When solving complex problems, such as the orthopedic device design control process, the incompetency and laziness from always “checking a box” can lead to disorder and a lack of productivity.

Copyright © 2020. All Rights Reserved.